Molecular Therapy-Methods & Clinical Development

Mol Ther Methods Clin Dev

2329-0501

Therapeutic Area

Cytology/Cell Biology, Genomics, Molecular Medicine, Pharmacology, Toxicology

Bioengineers, Biomedical Engineers/Technologists, Cell Biologists, Clinical Engineers, Clinical Microbiologists, Clinical Pharmacologists, Cytologists, Molecular Biologists, Scientists

The aim of Molecular Therapy—Methods & Clinical Development is to build upon the success of Molecular Therapy in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella. Topics of particular interest within the journal's scope include: Gene vector engineering and production; Methods for targeted genome editing and engineering; Methods and technology development for cell reprogramming and directed differentiation of pluripotent cells; Methods for gene and cell vector delivery; Development of biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine; Analysis of gene and cell vector biodistribution and tracking; Pharmacology/toxicology studies of new and next-generation vectors; Methods for cell isolation, engineering, culture, expansion, and transplantation; Cell processing, storage, and banking for therapeutic application; Preclinical and QC/QA assay development; Translational and clinical scale-up and Good Manufacturing procedures and process development; Clinical protocol development; Computational and bioinformatic methods for analysis, modeling, or visualization of biological data Negotiating the regulatory approval process and obtaining such approval for clinical trials.

American Society of Gene & Cell Therapy (ASGCT)

Cell Press

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines